Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072390123> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2072390123 endingPage "926" @default.
- W2072390123 startingPage "924" @default.
- W2072390123 abstract "Can independent scientific evaluation be sponsored by vested interests? The Cochrane Collaboration's decision on this question at its annual colloquium next week could have a big effect on its future As it turns 10 this month, the Cochrane Collaboration is at a crossroads, with its supporters deeply divided over whether to embrace drug company sponsorship. In just a decade the collaboration has fundamentally changed the way questions are asked and answered about what works and what doesn't in health care. Its rigorous methods for systematically reviewing and synthesising the best evidence have underpinned a collective move towards evidence based decision making among health professionals, policy makers, and consumers. Now, against a backdrop of growing global entanglement between doctors and drug companies, the collaboration must decide whether it can accept industry funding without compromising its reputation for integrity and independence.Delegates to next week's annual Cochrane Colloquium in Barcelona will debate the thorny question of conflict of interest at the opening plenary session and in a series of high level meetings.When the collaboration last got together in Melbourne in March, two senior professors of medicine ended up in a serious discussion about the issue, pre-empting the forthcoming conflict in Barcelona. One thought that the organisation might not be able to remain viable without industry support, whereas the other believed that the inevitable industry influence would destroy Cochrane's credibility.Drummond Rennie, codirector of the Cochrane Center in San Francisco and a deputy editor of JAMA, thinks industry funding would be a catastrophe for Cochrane. “It would be far better that some reviews are not done than reviewers accept money from interested parties,” he said. In contrast, Peter Tugwell, a member of Cochrane's international steering committee and professor of medicine at the University of Ottawa, is comfortable with reviews being funded by …" @default.
- W2072390123 created "2016-06-24" @default.
- W2072390123 creator A5035970804 @default.
- W2072390123 date "2003-10-18" @default.
- W2072390123 modified "2023-09-25" @default.
- W2072390123 title "Cochrane at crossroads over drug company sponsorship" @default.
- W2072390123 cites W1890496871 @default.
- W2072390123 cites W2016300030 @default.
- W2072390123 cites W2060924591 @default.
- W2072390123 cites W2132687977 @default.
- W2072390123 cites W2136284733 @default.
- W2072390123 cites W4210513276 @default.
- W2072390123 doi "https://doi.org/10.1136/bmj.327.7420.924" @default.
- W2072390123 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/218825" @default.
- W2072390123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14563759" @default.
- W2072390123 hasPublicationYear "2003" @default.
- W2072390123 type Work @default.
- W2072390123 sameAs 2072390123 @default.
- W2072390123 citedByCount "4" @default.
- W2072390123 countsByYear W20723901232019 @default.
- W2072390123 crossrefType "journal-article" @default.
- W2072390123 hasAuthorship W2072390123A5035970804 @default.
- W2072390123 hasBestOaLocation W20723901232 @default.
- W2072390123 hasConcept C127413603 @default.
- W2072390123 hasConcept C136764020 @default.
- W2072390123 hasConcept C162324750 @default.
- W2072390123 hasConcept C187736073 @default.
- W2072390123 hasConcept C2522767166 @default.
- W2072390123 hasConcept C2780035454 @default.
- W2072390123 hasConcept C2909375031 @default.
- W2072390123 hasConcept C2993777677 @default.
- W2072390123 hasConcept C41008148 @default.
- W2072390123 hasConcept C55587333 @default.
- W2072390123 hasConcept C71924100 @default.
- W2072390123 hasConcept C98274493 @default.
- W2072390123 hasConceptScore W2072390123C127413603 @default.
- W2072390123 hasConceptScore W2072390123C136764020 @default.
- W2072390123 hasConceptScore W2072390123C162324750 @default.
- W2072390123 hasConceptScore W2072390123C187736073 @default.
- W2072390123 hasConceptScore W2072390123C2522767166 @default.
- W2072390123 hasConceptScore W2072390123C2780035454 @default.
- W2072390123 hasConceptScore W2072390123C2909375031 @default.
- W2072390123 hasConceptScore W2072390123C2993777677 @default.
- W2072390123 hasConceptScore W2072390123C41008148 @default.
- W2072390123 hasConceptScore W2072390123C55587333 @default.
- W2072390123 hasConceptScore W2072390123C71924100 @default.
- W2072390123 hasConceptScore W2072390123C98274493 @default.
- W2072390123 hasIssue "7420" @default.
- W2072390123 hasLocation W20723901231 @default.
- W2072390123 hasLocation W20723901232 @default.
- W2072390123 hasLocation W20723901233 @default.
- W2072390123 hasLocation W20723901234 @default.
- W2072390123 hasOpenAccess W2072390123 @default.
- W2072390123 hasPrimaryLocation W20723901231 @default.
- W2072390123 hasRelatedWork W1506282065 @default.
- W2072390123 hasRelatedWork W2094512021 @default.
- W2072390123 hasRelatedWork W2107312434 @default.
- W2072390123 hasRelatedWork W2323581027 @default.
- W2072390123 hasRelatedWork W2351790455 @default.
- W2072390123 hasRelatedWork W2426261983 @default.
- W2072390123 hasRelatedWork W2748952813 @default.
- W2072390123 hasRelatedWork W2899084033 @default.
- W2072390123 hasRelatedWork W2900586034 @default.
- W2072390123 hasRelatedWork W2967274119 @default.
- W2072390123 hasVolume "327" @default.
- W2072390123 isParatext "false" @default.
- W2072390123 isRetracted "false" @default.
- W2072390123 magId "2072390123" @default.
- W2072390123 workType "article" @default.